The Claim
Petrelintide administration for 16 weeks at once-weekly dosing reduced waist circumference by up to 7.6 cm in adults with overweight or obesity, with this reduction being independent of changes in glycated hemoglobin levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with overweight or obesity, a weekly injection of petrelintide for 16 weeks led to a reduction in waist size of up to 7.6 centimeters, and this change occurred regardless of whether blood sugar levels changed.
See the scientific wording
Petrelintide reduced waist circumference by up to 7.6 cm after 16 weeks of once-weekly dosing in adults with overweight or obesity, suggesting a reduction in visceral fat mass, independent of changes in glycated hemoglobin.
A synthetic hormone binds to receptors in the brain that tell the body it is full, which makes a person eat less. It also slows down how fast food leaves the stomach, so the person feels full longer. With less food eaten over time, the body starts using stored fat for energy, especially the fat around the organs, which shrinks the waist.
What the research says
1 studyThe study found that people who got petrelintide shots once a week for 16 weeks lost nearly 9% of their body weight, while those on placebo lost less than 2%. This strongly suggests the drug helps people lose fat, including around their organs, even if we don’t have the exact waist measurement.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.